Compare NXT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXT | RVTY |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.8B |
| IPO Year | 2023 | 1994 |
| Metric | NXT | RVTY |
|---|---|---|
| Price | $100.80 | $95.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 15 |
| Target Price | $105.50 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 04-27-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | ★ 2.97 | N/A |
| EPS | ★ 2.86 | 2.07 |
| Revenue | $2,959,197,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $19.73 | $6.34 |
| Revenue Next Year | $11.74 | $5.10 |
| P/E Ratio | ★ $36.32 | $46.38 |
| Revenue Growth | ★ 18.38 | N/A |
| 52 Week Low | $36.06 | $81.36 |
| 52 Week High | $131.59 | $120.39 |
| Indicator | NXT | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 40.03 |
| Support Level | $84.48 | $94.57 |
| Resistance Level | $102.11 | $95.99 |
| Average True Range (ATR) | 7.05 | 3.45 |
| MACD | -2.95 | -0.20 |
| Stochastic Oscillator | 10.66 | 34.98 |
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.